Biologic differences between peripheral and transition zone prostate cancer

June 2017

Cancer

Country of origin: USA

Prostate cancer arises in the transition zone (TZ) in approximately 20–25% of cases. Modern biopsy and surveillance protocols, and advances in prostate cancer imaging, have renewed interest in TZ prostate cancers. We compared TZ and PZ prostate cancer to determine if cancer location is independently associated with better outcomes.

METHODS
We evaluated an expanded cohort of 1354 men who underwent radical prostatectomy between 1983 and 2003 with updated long-term clinical follow-up. Regression models were used to compare the volume of high-grade (Gleason 4 or 5) cancer and total cancer volume by location. Uni- and multi-variable logistic regression models tested the associations between cancer location and adverse pathologic features. Multivariable proportional hazard models were fit to examine cancer recurrence.

RESULTS
Patients with TZ cancer presented with higher pre-operative serum PSA values (11.07 vs. 7.86 ng/ml) and larger total cancer volume (7.1 vs. 3.8 cc). Patients with TZ cancer had decreased odds of seminal vesicle invasion (OR 0.08, 95% CI 0.03, 0.21), extra-capsular extension (OR 0.56, 95% CI 0.35, 0.92), and lymphovascular invasion (OR 0.48, 95% CI 0.27, 0.87) in multivariable models. TZ cancers were independently associated with decreased hazard of tumor recurrence (HR 0.62, 95% CI 0.43, 0.90).

CONCLUSIONS
TZ cancer prostate is associated with favorable pathologic features and better recurrence-free survival despite being diagnosed with larger cancers and higher PSA values. Tumor location should be taken into account when stratifying patient risk before and after prostatectomy, particularly with the evolving role of imaging in prostate cancer management. Prostate 75:183–190, 2015. © 2014 Wiley Periodicals, Inc.

Resources

inPractice® Oncology. December 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Manual for Cancer Services: Chemotherapy Measures November 2018 Following a three month consultation period the revised chemotherapy measures were published recently for inclusion in the...
QuitMedKit counseling and treatment of tobacco dependence October 2018 Tobacco use remains the number-one preventable cause of morbidity and mortality in the United States and worldwide. So it’s...
Sublux radiology app for all medical providers October 2018 What apps are available that teach the basics of plain radiography for more than just chest X-rays and ortho trauma? Are...
Study finds HPV from Oral Sex is linked to Throat Cancer September 2018 Oral sex increases the risk of transmitting the sexually transmitted human papillomavirus (HPV), suggests a new study...
Asian-language cancer information resource September 2018 About 4 million Asian Americans and Pacific Islanders have limited English proficiency, a disadvantage when it comes to...
Achieving world-class cancer outcomes: a strategy for England 2015-2020 August 2018 The Independent Cancer Taskforce has published Achieving world-class cancer outcomes: a strategy for England 2015-2020....
Living with and beyond cancer - improving future survivorship services August 2018 The National Cancer Survivorship Initiative (NCSI) has published Living with and Beyond Cancer: Taking Action to Improve...
Cancer System Performance August 2018 A website allows cancer patients, their families and health care providers in Ontario, Canada, to access the province's...
Cancer statistics: availability and location July 2018 Document aims to provide an overview about cancer statistics, including information on statistics publicly available and...
Search by Keyword